Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

Chun Ta Liao; Yu Wen Wen; Lan Yan Yang; Shu Ru Lee; Shu Hang Ng; Tsang Wu Liu; Sen Tien Tsai; Ming Hsui Tsai; Jin Ching Lin; Peir Rong Chen; Pei Jen Lou; Cheng Ping Wang; Pen Yuan Chu; Tzer Zen Hwang; Yi Shing Leu; Kuo Yang Tsai; Shyuang Der Terng; Tsung Ming Chen; Cheng Hsu Wang; Chih Yen Chien; Wen Cheng Chen; Li Yu Lee; Chien Yu Lin; Hung Ming Wang; Chia Hsun Hsieh; Chung Kan Tsao; Tuan Jen Fang; Shiang Fu Huang; Chung Jan Kang; Kai Ping Chang; Tzu Chen Yen

doi:10.1016/j.oraloncology.2017.02.011

Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

Chun Ta Liao, Yu Wen Wen, Lan Yan Yang, Shu Ru Lee, Shu Hang Ng, Tsang Wu Liu, Sen Tien Tsai, Ming Hsui Tsai, Jin Ching Lin, Peir Rong Chen, Pei Jen Lou, Cheng Ping Wang, Pen Yuan Chu, Tzer Zen Hwang, Yi Shing Leu, Kuo Yang Tsai, Shyuang Der Terng, Tsung Ming Chen, Cheng Hsu Wang, Chih Yen ChienWen Cheng Chen, Li Yu Lee, Chien Yu Lin, Hung Ming Wang, Chia Hsun Hsieh, Chung Kan Tsao, Tuan Jen Fang, Shiang Fu Huang, Chung Jan Kang, Kai Ping Chang, Tzu Chen Yen

Taipei Medical University Shuang Ho Hospital

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Objectives Although patients with buccal squamous cell carcinoma (SCC) usually show acceptable outcomes, local control and survival rates are generally lower than those observed for tongue SCC. This study was designed to compare the clinical outcomes of Taiwanese patients with these two common oral cavity malignancies. Methods Patients with first primary buccal or tongue SCC who were included in the Taiwanese Cancer Registry Database between 2004 and 2012 were eligible. The study sample consisted of 16,379 patients (7870 buccal SCC and 8509 tongue SCC) who received surgery with or without adjuvant therapy. The 5-year disease-specific survival (DSS) and overall survival (OS) rates served as the outcome measures. Results Compared with tongue SCC, patients with buccal SCC had a higher prevalence of males (95.7% vs. 86.4%, p < 0.0001), pT4 disease (21.4% vs. 12.7%, p < 0.0001), and p-Stage IV (30.4% vs. 24.8%, p < 0.0001) but a lower frequency of pN2 disease (15.2% vs. 18.5%, p < 0.0001). The 5-year DSS and OS rates of buccal SCC patients were slightly higher than those of tongue SCC (78% vs. 77%, p = 0.0297; and 71% vs. 69%, p = 0.0231, respectively). Multivariate analysis identified tumor site (tongue vs. buccal SCC), sex (male vs. female), age (≥65 vs. <65 years), pT classification (T4/T3/T2 vs. T1), and pN classification (N3/N2/N1 vs. N0) as independent prognostic factors in the entire study cohort. Conclusions The survival advantage of buccal SCC over tongue SCC appears significant in large clinical samples, despite a higher prevalence of p-Stage IV disease in the former.

Original language	English
Pages (from-to)	95-102
Number of pages	8
Journal	Oral Oncology
Volume	67
DOIs	https://doi.org/10.1016/j.oraloncology.2017.02.011
Publication status	Published - Apr 1 2017

Keywords

Buccal mucosa
Cancer Registry
Prognosis
Squamous cell carcinoma
Tongue

ASJC Scopus subject areas

Oral Surgery
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.oraloncology.2017.02.011

Cite this

Liao, C. T., Wen, Y. W., Yang, L. Y., Lee, S. R., Ng, S. H., Liu, T. W., Tsai, S. T., Tsai, M. H., Lin, J. C., Chen, P. R., Lou, P. J., Wang, C. P., Chu, P. Y., Hwang, T. Z., Leu, Y. S., Tsai, K. Y., Terng, S. D., Chen, T. M., Wang, C. H., ... Yen, T. C. (2017). Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas. Oral Oncology, 67, 95-102. https://doi.org/10.1016/j.oraloncology.2017.02.011

Liao, CT, Wen, YW, Yang, LY, Lee, SR, Ng, SH, Liu, TW, Tsai, ST, Tsai, MH, Lin, JC, Chen, PR, Lou, PJ, Wang, CP, Chu, PY, Hwang, TZ, Leu, YS, Tsai, KY, Terng, SD, Chen, TM, Wang, CH, Chien, CY, Chen, WC, Lee, LY, Lin, CY, Wang, HM, Hsieh, CH, Tsao, CK, Fang, TJ, Huang, SF, Kang, CJ, Chang, KP & Yen, TC 2017, 'Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas', Oral Oncology, vol. 67, pp. 95-102. https://doi.org/10.1016/j.oraloncology.2017.02.011

@article{61ce0637d60345069c0ebd13b6572a20,

title = "Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas",

abstract = "Objectives Although patients with buccal squamous cell carcinoma (SCC) usually show acceptable outcomes, local control and survival rates are generally lower than those observed for tongue SCC. This study was designed to compare the clinical outcomes of Taiwanese patients with these two common oral cavity malignancies. Methods Patients with first primary buccal or tongue SCC who were included in the Taiwanese Cancer Registry Database between 2004 and 2012 were eligible. The study sample consisted of 16,379 patients (7870 buccal SCC and 8509 tongue SCC) who received surgery with or without adjuvant therapy. The 5-year disease-specific survival (DSS) and overall survival (OS) rates served as the outcome measures. Results Compared with tongue SCC, patients with buccal SCC had a higher prevalence of males (95.7% vs. 86.4%, p < 0.0001), pT4 disease (21.4% vs. 12.7%, p < 0.0001), and p-Stage IV (30.4% vs. 24.8%, p < 0.0001) but a lower frequency of pN2 disease (15.2% vs. 18.5%, p < 0.0001). The 5-year DSS and OS rates of buccal SCC patients were slightly higher than those of tongue SCC (78% vs. 77%, p = 0.0297; and 71% vs. 69%, p = 0.0231, respectively). Multivariate analysis identified tumor site (tongue vs. buccal SCC), sex (male vs. female), age (≥65 vs. <65 years), pT classification (T4/T3/T2 vs. T1), and pN classification (N3/N2/N1 vs. N0) as independent prognostic factors in the entire study cohort. Conclusions The survival advantage of buccal SCC over tongue SCC appears significant in large clinical samples, despite a higher prevalence of p-Stage IV disease in the former.",

keywords = "Buccal mucosa, Cancer Registry, Prognosis, Squamous cell carcinoma, Tongue",

author = "Liao, {Chun Ta} and Wen, {Yu Wen} and Yang, {Lan Yan} and Lee, {Shu Ru} and Ng, {Shu Hang} and Liu, {Tsang Wu} and Tsai, {Sen Tien} and Tsai, {Ming Hsui} and Lin, {Jin Ching} and Chen, {Peir Rong} and Lou, {Pei Jen} and Wang, {Cheng Ping} and Chu, {Pen Yuan} and Hwang, {Tzer Zen} and Leu, {Yi Shing} and Tsai, {Kuo Yang} and Terng, {Shyuang Der} and Chen, {Tsung Ming} and Wang, {Cheng Hsu} and Chien, {Chih Yen} and Chen, {Wen Cheng} and Lee, {Li Yu} and Lin, {Chien Yu} and Wang, {Hung Ming} and Hsieh, {Chia Hsun} and Tsao, {Chung Kan} and Fang, {Tuan Jen} and Huang, {Shiang Fu} and Kang, {Chung Jan} and Chang, {Kai Ping} and Yen, {Tzu Chen}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.oraloncology.2017.02.011",

language = "English",

volume = "67",

pages = "95--102",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

AU - Liao, Chun Ta

AU - Wen, Yu Wen

AU - Yang, Lan Yan

AU - Lee, Shu Ru

AU - Ng, Shu Hang

AU - Liu, Tsang Wu

AU - Tsai, Sen Tien

AU - Tsai, Ming Hsui

AU - Lin, Jin Ching

AU - Chen, Peir Rong

AU - Lou, Pei Jen

AU - Wang, Cheng Ping

AU - Chu, Pen Yuan

AU - Hwang, Tzer Zen

AU - Leu, Yi Shing

AU - Tsai, Kuo Yang

AU - Terng, Shyuang Der

AU - Chen, Tsung Ming

AU - Wang, Cheng Hsu

AU - Chien, Chih Yen

AU - Chen, Wen Cheng

AU - Lee, Li Yu

AU - Lin, Chien Yu

AU - Wang, Hung Ming

AU - Hsieh, Chia Hsun

AU - Tsao, Chung Kan

AU - Fang, Tuan Jen

AU - Huang, Shiang Fu

AU - Kang, Chung Jan

AU - Chang, Kai Ping

AU - Yen, Tzu Chen

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objectives Although patients with buccal squamous cell carcinoma (SCC) usually show acceptable outcomes, local control and survival rates are generally lower than those observed for tongue SCC. This study was designed to compare the clinical outcomes of Taiwanese patients with these two common oral cavity malignancies. Methods Patients with first primary buccal or tongue SCC who were included in the Taiwanese Cancer Registry Database between 2004 and 2012 were eligible. The study sample consisted of 16,379 patients (7870 buccal SCC and 8509 tongue SCC) who received surgery with or without adjuvant therapy. The 5-year disease-specific survival (DSS) and overall survival (OS) rates served as the outcome measures. Results Compared with tongue SCC, patients with buccal SCC had a higher prevalence of males (95.7% vs. 86.4%, p < 0.0001), pT4 disease (21.4% vs. 12.7%, p < 0.0001), and p-Stage IV (30.4% vs. 24.8%, p < 0.0001) but a lower frequency of pN2 disease (15.2% vs. 18.5%, p < 0.0001). The 5-year DSS and OS rates of buccal SCC patients were slightly higher than those of tongue SCC (78% vs. 77%, p = 0.0297; and 71% vs. 69%, p = 0.0231, respectively). Multivariate analysis identified tumor site (tongue vs. buccal SCC), sex (male vs. female), age (≥65 vs. <65 years), pT classification (T4/T3/T2 vs. T1), and pN classification (N3/N2/N1 vs. N0) as independent prognostic factors in the entire study cohort. Conclusions The survival advantage of buccal SCC over tongue SCC appears significant in large clinical samples, despite a higher prevalence of p-Stage IV disease in the former.

AB - Objectives Although patients with buccal squamous cell carcinoma (SCC) usually show acceptable outcomes, local control and survival rates are generally lower than those observed for tongue SCC. This study was designed to compare the clinical outcomes of Taiwanese patients with these two common oral cavity malignancies. Methods Patients with first primary buccal or tongue SCC who were included in the Taiwanese Cancer Registry Database between 2004 and 2012 were eligible. The study sample consisted of 16,379 patients (7870 buccal SCC and 8509 tongue SCC) who received surgery with or without adjuvant therapy. The 5-year disease-specific survival (DSS) and overall survival (OS) rates served as the outcome measures. Results Compared with tongue SCC, patients with buccal SCC had a higher prevalence of males (95.7% vs. 86.4%, p < 0.0001), pT4 disease (21.4% vs. 12.7%, p < 0.0001), and p-Stage IV (30.4% vs. 24.8%, p < 0.0001) but a lower frequency of pN2 disease (15.2% vs. 18.5%, p < 0.0001). The 5-year DSS and OS rates of buccal SCC patients were slightly higher than those of tongue SCC (78% vs. 77%, p = 0.0297; and 71% vs. 69%, p = 0.0231, respectively). Multivariate analysis identified tumor site (tongue vs. buccal SCC), sex (male vs. female), age (≥65 vs. <65 years), pT classification (T4/T3/T2 vs. T1), and pN classification (N3/N2/N1 vs. N0) as independent prognostic factors in the entire study cohort. Conclusions The survival advantage of buccal SCC over tongue SCC appears significant in large clinical samples, despite a higher prevalence of p-Stage IV disease in the former.

KW - Buccal mucosa

KW - Cancer Registry

KW - Prognosis

KW - Squamous cell carcinoma

KW - Tongue

UR - http://www.scopus.com/inward/record.url?scp=85013141413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013141413&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2017.02.011

DO - 10.1016/j.oraloncology.2017.02.011

M3 - Article

C2 - 28351587

AN - SCOPUS:85013141413

SN - 1368-8375

VL - 67

SP - 95

EP - 102

JO - Oral Oncology

JF - Oral Oncology

ER -

Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this